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CRITICALLY APPRAISED TOPIC 
 
The Effects of the Inclusion of a Bobath Based Approach in the Rehabilitative 
Treatment of Patients Post Stroke Resulting in Hemiparesis  
 
Clinical Scenario: The patient of interest was a 63 year old male who presented to the 
hospital with right sided weakness, dysarthria, and headache.  Imaging revealed an 
acute ischemic cerebrovascular accident (CVA) involving the left middle cerebral artery.  
He received a physical therapy evaluation within 24 hours of his stroke and presented 
with less than 3/5 strength in his right upper extremity and 3-3+/4 strength in his right 
lower extremity.  Prior to the stroke, the patient was independent with activities of daily 
living and lead an active lifestyle.  He lived alone in a single level house. 
 
Introduction:  The Bobath, or Neurodevelopmental approach (NDT), is a rehabilitative 
treatment approach for patients with neurological conditions.  It was established by 
Berta and Karel Bobath in the 1950s and focuses on recovery rather than 
compensation.  Treatments are individualized and focus primarily on improving postural 
control and coordination throughout movement sequences.  Sensory input and manual 
facilitation is provided throughout treatment to enhance motor control and motor 
learning.  Treatment also focuses on the efficiency of movement and often aims to limit 
compensatory movement patterns.  Other current treatment approaches may be 
impairment based or focus on early accomplishment of tasks regardless of movement 
sequence.  Additionally, many current treatment approaches include repetitive task 
practice to increase function.  It is important to note that the Bobath approach has 
evolved over the decades to adapt to contemporary neurological and rehabilitative 
sciences.  The focus of the Bobath concept used to be in reducing spasticity in order to 
minimize compensatory movements and to facilitate any missing components or 
positions of a normal developmental sequence.1,12  The Bobath concept has developed 
and spasticity is now considered a contributing factor to movement dysfunction instead 
of being the primary cause.  Clinicians work with patients to improve muscle contraction 
and activation patterns, but do not limit functional progression if tone is still present.1  
Additionally, reflexes are now understood as reactions to support movement rather than 
primitive movement patterns.12  Task specific practice in different contexts and 
environments is now included in accordance with modern principles of motor learning.  
Research on the Bobath approach does not often reflect the developments made to the 
theory and clinical trials do not usually provide a detailed account of therapeutic 
interventions.  Therefore, it is difficult to ascertain what version of a Bobath based 
approach is being implemented. The focus on sensory input and manual facilitation to 
enhance postural control is still a tenet of the approach and separates it from other 
treatment approaches.  The aim of this critically appraised topic is to decipher if the 
inclusion of the Bobath approach in stroke rehabilitation provides any substantial benefit 
to the patient with the understanding that there may be some overlap in treatment 
approaches due to the modernization of the theory. 
 
 
  
Clinical question: Does the inclusion of the Bobath/Neurodevelopmental Approach in 
treating hemiparetic patients post cerebrovascular accident improve gait and function 
more than interventions without it? 
 
Clinical Question PICO: 
Population – Older adults with hemiparesis post acute cerebrovascular accident 
 
Intervention – Care that includes the Bobath/Neurodevelopmental Approach  
 
Comparison – Care that does not include the Bobath/Neurodevelopmental Approach 
 
Outcome – Gait speed, standardized functional outcome assessments 
 
 
Overall Clinical Bottom Line:  Based on the results of this critically appraised topic, 
there is moderate evidence to suggest that for patients post CVA resulting in 
hemiparesis an intervention based on the Bobath approach provides similar outcomes 
in function to other treatment approaches.  In all four articles, subjects that received 
Bobath based treatment initiated in an acute care setting demonstrated statistically 
significant increases in function.  However, the increases in function were either not 
statistically different than the improvements noted in comparison groups or Bobath 
group effect sizes were slightly lower than comparison groups.  In Gelber et al., there 
was no difference found between the Bobath approach and the Traditional Functional 
Retraining group in regards to gait speed or the Functional Independence Measure.  
Wang et al. found the Bobath group improvement on the Berg Balance Scale was no 
different than subjects who received an orthopedic approach.  Subjects in the Bobath 
group did have a greater improvement on the MAS, but the fair internal validity of this 
study slightly limited its usefulness.  Van Vliet et al. had good internal validity and 
provided moderate evidence that the Bobath approach was similar to a Movement 
Science Based approach because there was no difference between group improvement 
on the Rivermead Motor Scale, Motor Assessment Scale, or gait speed.  Lastly, 
Langhammer et al provided moderate evidence that the Bobath approach was slightly 
less favorable when compared to a Motor Relearning Program (MRP) on the Sodring 
Motor Evaluation Scale and Motor Assessment Scale.  Between group analysis 
revealed a small effect size favoring the MRP group, but the lower end of the 
confidence interval crossed zero indicating that in future trials the Bobath approach 
could have been more effective.  The MRP group did have a statistically significant 
shorter length of hospital stay.  Therefore,  the inclusion of a Bobath approach did not 
provide any additional increases in patient function than comparison treatments did. 
 
As mentioned previously, the Bobath approach now includes task specific practice with 
a focus on normalizing tone and movement sequence. It is important to note that the 
four articles examined in this review focused on an earlier interpretation of the approach 
where task specific training is not included.  Therefore, future research on the subject is 
required to ascertain as to how beneficial the Bobath approach is in combination with 
task specific practice.      
Search Terms: Bobath, Neurodevelopmental Approach, stroke rehabilitation, 
cerebrovascular accident, hemiparesis, facilitation 
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Rationale for your chosen articles:  The following four articles all included a Bobath 
approach compared to a different treatment approach with subjects randomly allocated 
to either group.   All treatments were initiated in an acute care setting and included 
subjects post CVA specifically resulting in hemiparesis.  Additionally, all four articles 
included valid and reliable tools to assess function.  The comparison groups in all four 
articles were similar and were either based on task specific training or orthopedic 
approaches.  Therefore, the similarity of study design between the articles and similarity 
to the patient of interest made these the best choices to examine the effectiveness of 
the Bobath approach.   
 
 
Table 1. Comparison of PEDro Scores 
 
 
Gelber Wang Van Vliet Langhammer 
Random 1 1 1 1 
Concealed allocation 0 1 1 1 
Baseline comparability 0 0 1 1 
Blind Subjects 0 0 0 1 
Blind Therapists 0 0 0 0 
Blind Assessors 0 1 1 1 
Adequate Follow-up 1 1 1 1 
Intention-to-Treat 0 1 1 0 
Between Group 1 1 1 1 
Point Estimates & 
Variability 
1 1 1 1 
Total Score 4 8 8 8 
Article 1: Gelber DA, Josefczy PB, Herrman D, Good DC and Verhulst SJ. Comparison 
of two therapy approaches in the rehabilitation of the pure motor hemiparetic. Journal of 
Neurological Rehabilitation 1995; 9: 191–196. 
 
Clinical Bottom Line: Based on the results of this study, there is insufficient  evidence 
to suggest that for subjects post acute stroke resulting in hemiparesis interventions 
based on the Neurodevelopmental (NDT) approach result in more favorable outcomes 
in gait and function when compared to a Traditional Functional Retraining approach 
(TFR).  Subjects in both treatment groups surpassed the minimum clinically important 
difference (MCID) of 22 points on the Functional Independence Measure (FIM) between 
admission and discharge.  The authors reported no statistically significant difference 
between groups when comparing change scores at discharge or at a 1 year.  The effect 
size at both assessments favored the NDT group, but the lower value of the confidence 
interval for both effect sizes was negative demonstrating that if the study were repeated 
the outcome may have favored the other treatment approach. Although subjects in the 
NDT group did experience significantly greater increases in gait speed at discharge 
(p<0.04) change scores were not provided, so an effect size could not be calculated.  
Additionally, methodology regarding gait assessments limited the usefulness of this 
assessment.  Groups were not similar in mean gait speed at baseline and a different 
number of subjects were included in gait assessments at each interval. Other significant 
threats to the internal validity in this study were lack of blinding of assessors, insufficient 
power, and lack of an intention to treat analysis for subjects lost before the 1 year 
follow-up.  The lack of power presented a type 2 error where a difference that may have 
existed between groups was not illustrated. Although the study matched the population 
of interest, further research with a larger number of subjects and blinding is necessary 
to apply conclusions about which treatment method is preferable.  Additionally, it may 
have been beneficial to use a functional outcome measure that provided insight into 
quality of movement versus accomplishment of tasks. 
 
Article PICO: 
• Population: 27 pure motor ischemic stroke survivors with hemiparesis no 
greater than 1 month post stroke 
• Intervention: Neurodevelopmental approach  
• Comparison: Traditional functional retraining approach 
• Outcome: Gait speed and Functional Independence Measure 
 
 
Blinding: Therapists, subjects, and assessors were not blinded during this study.  It 
was not feasible to blind therapists to group allocation because physical and 
occupational therapists received specific training in order to ensure they provided 
consistent interventions.  Outcome measures were assessed by therapists not blinded 
to group allocation.  It was not specified whether the therapists conducting assessments 
were different from those providing treatments.  
 
 
Controls: Controls included randomized group allocation, inclusion of a control group, 
similarity of subjects at baseline, and the use of valid outcome measures.  The control 
group in this study received the TFR approach because it would have been unethical to 
not provide rehabilitation services to subjects post stroke.  This served as an adequate 
control because subjects in the TFR group did not receive emphasis on quality of 
movement, inhibition of tone, and use of the hemiparetic side as in the NDT group.  
Additionally, only the TFR group received range of motion and progressive resistive 
exercises. 
 
Subjects in both groups had a similar length of stay: 27.3 days for the NDT group and 
25.2 days for the TFR group.  The subjects in the TFR group were enrolled 2 days later 
than the NDT group resulting in a length of stay of roughly 25 days for both groups.  
Frequency and duration of treatments were not specified so it is possible that the 
amount of therapy was not consistent between groups. 
 
 
Randomization: Subjects were randomly assigned to the NDT or TFR group. 
 Randomization was successful because there were no significant differences between 
the two groups at baseline in terms of age, gender, side of stroke, or time since 
cerebrovascular accident.  
 
 
Study: This study consisted of  27 subjects post pure motor ischemic stroke resulting in 
hemiparesis.  The mean number of days post stroke was 12.  Subjects consisted of a 
convenience sample from a single acute inpatient rehabilitation center.  Inclusion criteria 
consisted of onset of stroke resulting in hemiparesis within the past month.  Subjects 
were excluded if they had nonischemic strokes, cognitive or language deficits, visual or 
sensory deficits, bilateral motor deficits, history of a prior stroke, or history of regular use  
of an assistive device.  
 
Fifteen subjects were randomized into the NDT intervention group and 12 were 
randomized into the TFR intervention group.  The average age of subjects in the NDT 
groups was 73.8 years and 69.8 years in the TFR group.  Treatment sessions in the 
NDT group aimed to decrease abnormal tone and associated reactions.  The focus was 
to promote normal movement patterns and emphasize weight-bearing through the 
hemiparetic side before progression to functional tasks.  Subjects did not participate in 
resistive exercises.  Subjects in the TFR group participated in range of motion 
exercises, resistive exercises, and functional task practice without emphasis on whether 
or not reflexes or spasticity were present.  Subjects in the TFR group also received 
early use of assistive devices and braces if applicable.   
 
Both groups received treatments based on the designated approach from physical and 
occupational therapists throughout their stay.   Additionally, nursing staff was trained in 
the various techniques to facilitate transfers in a similar manner to those during therapy 
sessions.  Frequency and duration were not specified. 
 
Outcome measures: The outcome measures related to function and gait speed were 
relevant to the clinical question.  Function was rated by the FIM.  Gait was measured if 
subjects were able to ambulate 50 feet with or without an assistive device.  Gait velocity 
was averaged over three trials of ambulation with five minute rest periods in between.  
Subjects were rated at admission, discharge, six months post discharge, and 1 year 
post discharge.   
 
The FIM is an assessment tool to measure independence with functional mobility and 
activities of daily living  most often used during a hospitalization.  It is composed of 18 
specific tasks that are related to motor and cognitive abilities for a total of 126 available 
points.  Each item is scored between 1 and 7 points with a score of 1 reflecting total 
assistance needed for that particular task and a score of 7 indicating complete 
independence.  The motor subscale compromises 13 of the 18 items and includes 
activities of daily living and mobility.  The mobility items most pertinent to this clinical 
question are transfers from a bed to a chair, toilet transfers, bath/shower transfers, 
ambulation, and stair navigation.  Cognitive task items are related to comprehension, 
expression, social interaction, problem solving, and memory. 
The authors did not address the reliability, validity, or minimal clinically important MCID 
with regards to the FIM or gait speed.  Additionally, they did not comment on the 
inter/intra-rater reliability for either outcome measure.  The FIM has been established as 
a reliable and valid tool to assess function in the stroke population and an MCID of 22 
points has been established specifically for the stroke population.2  Gait speed is also a 
valid and reliable mobility measurement tool in subjects with neurologic impairment and 
an MCID of 0.16 m/s has been established in the stroke population.3,4   Additionally a 
gait speed of < .56 m/s is predictive of falls.5 
 
Study losses: Before the six month follow up assessment, 1 member of the NDT group 
died and 3 members the TFR group died.  Additionally, 7 subjects did not return for their 
6 month and 1 year assessments and FIM scores were collected over the phone.  The 
authors did not specify why the 7 subjects did not return or which treatment group they 
were from.  An intention to treat analysis was not performed. 
 
 
Summary of internal validity: Overall this study demonstrated poor internal validity. 
Strengths of the study were adequate definitions of inclusion and exclusion criteria, 
random allocation to treatment groups, subjects were similar at baseline, and inclusion 
of long term follow-up assessments.   
 
Several threats to internal validity were maturation, testing effect, selection and lack of 
blinding.  Maturation was a minor threat because subjects who experience pure motor 
lacunar infarcts usually experience spontaneous recovery.6  Therefore, it is likely that a 
certain level of recovery occurred regardless of rehabilitation intervention.  However, it 
is reasonable to expect that subjects across groups had a comparable rate of natural 
recovery due to similarities in stroke type and onset of stroke. Testing effect was also a 
minor threat since subjects likely performed better each time they received a particular 
assessment.  Selection was a minor threat to the study since subjects were a 
convenience sample chosen from a single inpatient rehabilitation clinic. Lastly, lack of 
blinding introduced a moderate threat of rater bias. 
 
This study presented poor statistical validity.  First, the authors used valid and reliable 
assessment tools, but did not provide specific motor subscale scores for the FIM. 
Although subjects with cognitive deficits were excluded, it is still possible that the 
inclusion of cognitive scores made it possible that improvements in mobility were not 
reflected if subjects experienced a simultaneous decline in cognition.  Secondly, a 
straightforward comparison between the groups in regards to change in gait speed was 
not possible for several reasons.  Gait speed was not similar at baseline between 
groups and subjects were assessed as they were able to ambulate.  Thus, the mean 
speed at discharge included data for subjects not analyzed upon admittance. Lastly, the 
largest threat to statistical validity was the lack of adequate power.  A total of 27 
subjects were randomized into groups of 12 and 15.  However, a power analysis 
revealed that a minimum of 26 subjects per group were necessary to reach 80% power. 
This introduced a type 2 error where a potential existing difference between groups was 
not discovered because there weren’t enough subjects to demonstrate it.   
 
All subjects in this study were included in the baseline and discharge assessments.  
These findings are most pertinent to the clinical question because the patient was 
encountered in an acute care setting.  However, 4 subjects died before the follow- up 
assessments and an intention to treat analysis was not performed.  Therefore, long term 
follow- up assessments do not reflect how the scores would have changed if the 
subjects had an unfavorable response to the treatment.  Additionally, seven subjects 
that did not return for the follow-up assessments were evaluated on the FIM over the 
phone introducing bias.  
 
 
Evidence: 
The outcomes of the FIM and gait speed at admission and discharge were of particular 
interest to this clinical question.  The FIM score was rated at admission for all subjects 
and data was assessed with a  Student’s t-test.   
 
Table 2: FIM admission scores,  FIM mean change scores at discharge, and MCID. 
Group Mean FIM Score at 
Admission 
Mean Change of FIM 
Score after Discharge 
 Met MCID 
NDT Group 
(n=15) 
77.9 (± 3.8) 23.3 (± 1.9) yes 
TFR Group 
(n=12) 
82.1 (± 5.8) 22.5 (± 2.3) yes 
The authors reported that groups were not different at baseline in regards to the FIM.  
Both groups met the MCID of 22 points.  
 
 
Table 3: Mean difference and effect size between the NDT and TFR groups at 
discharge 
Mean difference between groups (95% CI) Effect Size 
(95% CI) 
0.8 (-0.90 to 2.50) 0.38 (-0.38 to 1.15) 
Table 3 shows the calculated mean difference between the change scores and the 
effect size.  The author’s reported there was no significant difference in change scores 
between groups suggesting that both treatments had an equitable effect.  The between 
group effect size was small (0.38) and favored the NDT treatment.  However, the lower 
end of the 95% confidence interval crossed zero indicating that if this study were 
repeated the results could have favored the TFR group.  Therefore, there is less 
confidence the NDT approach is a superior treatment. 
 
 
Table 4:  FIM score at admission, mean change scores on the FIM after 1 year and 
MCID 
Group Mean FIM Score at 
Admission 
Mean Change of FIM 
Score after 1 year 
 Met MCID 
NDT 
Group 
(n=14) 
77.9 (± 3.8) 31.9 (± 4.0) yes 
TFR Group 
(n=9) 
82.1 (± 5.8) 28.9 (± 4.7) yes 
Table 4 illustrates FIM changes scores at 1 year follow-up.  There was no statistical 
difference noted between groups although both demonstrated continued improvements 
post discharge.   
 
 
Table 5 : Calculated mean difference and effect Size between the NDT and TFR 
groups at 1 year  
Mean difference between groups (95% CI) Effect Size 
(95% CI) 
3 (-0.79 to 6.79) 0.70 (-0.16 to 1.56) 
Table 5 shows the mean difference between the change scores and the effect size of 
the difference.  The effect size was medium and once again favored the NDT group.  
However, the lower end of the confidence interval was negative indicating if the study 
were repeated the results would not necessarily favor the NDR group. 
 
 
Table 6 : Authors’ Reported Measurements of Gait Speed on Admission and at 
Discharge 
Group Mean Gait Speed at 
Admission (m/s) 
Mean Gait Speed at 
Discharge (m/s) 
MCID (m/s) 
NDT  (n=3)  0.55 (± 0.12) (n=6)  0.52 (± 0.09) 0.16 
TFR (n=7)  0.18 (± 0.6) (n=6)  0.21 (± 0.4) 0.16 
Table 6 shows the authors provided mean gait speeds at admission and discharge.  
Mean change scores for gait speed were not provided.  Therefore, it was not possible to 
calculate an effect size. Subjects were not similar at baseline in gait speed and subjects 
were added as they were able to ambulate.  Although the authors did report a significant 
difference between discharge gait speed favoring the NDT group (p=0.04), the 
inconsistency between subjects included in assessments and small power make these 
results unreliable.    
 
 
Applicability of study results: 
 
Benefits vs. Costs: The length of stay during hospitalization was similar for both 
intervention groups as mentioned previously.  A large part of discharge planning for 
subjects post stroke is assessment of functional level.  Since there was no difference 
between groups in FIM change scores, there is insufficient evidence to say that 
including the Bobath approach is any more or less beneficial than a  traditional 
functional retraining approach.  The authors did not report on the specific amount of 
time each group received therapy so there is no evidence as to which intervention was 
more time efficient  However, both treatment groups benefited from therapy services 
and had clinically meaningful changes in functional outcomes.  However, the FIM does 
not capture quality or ease of movement, but rather the amount of assistance a person 
needs with a task.  It is possible that the Bobath approach resulted in more typical 
movement patterns which would theoretically conserve energy for the subject, but this 
study did not explore that potential benefit. 
 
Feasibility of treatment: The principles behind both of the treatment approaches were 
described by the authors.  However, specific details describing treatment sessions and 
frequency were not provided.  Therefore, it would not be possible to specifically 
replicate the treatments provided to patients in this particular study.  However, both 
treatments approaches were appropriate in terms of increasing independence with 
activities of daily living and functional mobility. 
 
Summary of external validity:  The patient population in this study matched the 
population of interest in acuity of stroke, age, and resulting motor impairments.  
Additionally, the interventions were feasible to perform in a rehabilitation setting and the 
authors included a long term follow-up.  However, the internal validity of this study was 
poor which compromises the ability to generalize these results to the larger population 
of patients post stroke resulting in hemiparesis.  Additionally, a minor threat to the 
external validity was that the subjects were a sample of convenience from a single 
clinic.  
 
 
Article 2: Wang RY, Chen HI, Chen CY and Yang YR. Efficacy of Bobath versus 
orthopedic approach on impairment and function at different motor recovery stages after 
stroke: a randomized controlled study. Clinical Rehabilitation 2005; 19: 155–164. 
 
Clinical Bottom Line: Based on the results of this study, there is weak evidence to 
suggest that for subjects with hemiparesis post acute stroke in Brunstrom stages 2-3   
rehabilitation based on the Bobath approach results in significantly greater increases in 
function according to the Motor Assessment Scale (MAS) when compared to an 
orthopedic approach.  The Bobath group of subjects with spasticity had a statistically 
significantly greater improvement in change on the MAS with a large effect size of  1.17 
(95% CI 0.24 to 2.10).  There was no difference in change between groups in regards to 
the Berg Balance Scale (BBS) although both groups improved significantly and 
surpassed the minimum detectable change (MDC) of 6.9 points.  
 
Although the assessors were blinded, the outcome measures were scored according to 
subjective rankings which introduce some rater bias.  Additionally, it was unclear if 
subjects were similar in baseline on the BBS.  Both outcome tools were reliable and 
valid, but neither has an established meaningful clinically important difference (MCID) 
making it difficult to determine how relevant improvements in function were.  It would be 
beneficial to have future research on this subject with larger group sizes, outcome 
measures with established MCID’s, and inclusion of assessment tools with continuous 
data such as gait speed. 
 
Article PICO: 
• Population: 44 stroke survivors with hemiparesis   
• Intervention: Bobath treatment program 
• Comparison: Orthopedic treatment program 
• Outcome measures: Motor Assessment Scale, Berg Balance Scale 
 
 
Blinding: Therapists and subjects were not blinded.  Therapist blinding was not 
possible because therapists adhered to strict protocols according to Bobath and Davis 
textbooks and had received advanced training in these techniques.  Additionally, 
therapists treating in the orthopedic group had extensive experience working with stroke 
survivors and providing orthopedic based treatments.  Assessors were blinded to group 
allocation and not involved in treatments.   
 
 
Controls: Controls included randomized group allocation, blinding of assessors, use of 
valid outcome measures, and stratification into groups based on Brunnstrom stages of 
motor recovery.  The comparison group in this study received an orthopedic approach 
because it would have been unethical to not provide rehabilitation services to subjects 
post stroke.  This served as an adequate control because subjects in the orthopedic 
group did not receive manual or proprioceptive facilitation or exercises to increase 
postural control which are the basic tenants of the Bobath approach.  Additionally, 
subjects in the orthopedic group did not have techniques provided to reduce tone or 
inhibit spasticity during movement.  Subjects also followed a strict protocol and had the 
same frequency and duration of treatment.   
 
 
Randomization: Subjects were allocated to groups via sealed envelopes administered 
by an independent study participant.  Subjects with were similar in demographics.  It 
was unclear if subjects with spasticity were similar at baseline in regards to the BBS 
and, therefore, it is not clear if randomization was successful. 
 
 
Study:  This randomized, controlled trial compared the effectiveness of the Bobath 
treatment approach to an orthopedic approach in the rehabilitation of stroke survivors.  
Subjects were a convenience sample of 44 stroke survivors from a single inpatient 
rehabilitation center.  Inclusion criteria were hemiparesis resulting from a recent 
cerebrovascular accident, lower extremity Brunnstrom stage 2-5 of motor recovery, and 
the ability to communicate. Twenty-one subjects in Brunnstrom stages 2 or 3 were 
stratified into a “spasticity” group and twenty-three subjects in Brunnstrom stages 4 or 5 
were stratified into a “relative recovery” group.  Subjects were then randomized into 
either a Bobath or orthopedic treatment group.   
 
The subjects with spasticity were relevant to this clinical question because they were 
the most similar to the demographics of the patient of interest.  Subjects in the Bobath 
group had a mean age of 53.9 (± 11.8) and were 21.9 (± 7.4) days post stroke.  
Subjects in the orthopedic group had a mean age of 59.3 (± 12.2) and were  20.7 (± 5.9) 
days post stroke.  
 
Subjects in both groups received 40 minute treatments 5 times a week for 4 weeks.  
Subjects in the Bobath group had treatments based on retraining normal movement 
patterns and received manual, sensory, and proprioceptive facilitation.   Efforts were 
made to reduce tone and train postural control for dynamic balance activities and 
functional movement patterns.  Subjects in the orthopedic group received impairment 
based treatments including range of motion exercises, resistive exercises and multiple 
repetitions of functional activities such as transfers and gait. 
 
Outcome measures:  Subjects were assessed at baseline and after the treatment.  
Outcome measures pertinent to this clinical question were MAS and the BBS.  
Assessments were taken by physical therapists who did not treat the groups and who 
were blinded to group allocation. 
 
The MAS is a clinical scale involving 8 areas of motor function.  The authors in this 
study only assessed the five areas that were pertinent to functional mobility which 
included rolling, supine to sit transfers, static sitting, sit to stand transfers, and gait.  
Each item is scaled from 0 to 6 for a total of 30 available points.  The authors cited that 
the MAS is a reliable scale.  It has also been demonstrated as a valid outcome 
assessment tool in the stroke population.7  There is no MCID or minimum detectable 
change (MDC) established in the literature for this assessment tool. 
 
The BBS assesses a subjects ability to perform 14 tasks including sitting, standing, 
turning, reaching, and stepping.  Subjects are rated from 0 (cannot perform) to 4 
(normal performance) for a total of 56 available points.  The authors cited that the BBS 
has excellent reliability and validity.  An MCID has not been established in the literature, 
but a MDC of 6.9 points has been identified for the stroke population.8 
 
Study losses:  All subjects completed the trial. 
 
 
Summary of internal validity:  Overall this study demonstrated fair internal validity. 
Strengths of the study were adequate definitions of inclusion criteria, stratification, 
random allocation to treatment groups, blinding of assessors, and adherence to a strict 
protocol.  Additionally, all subjects completed the trial and authors used valid and 
reliable outcome tools.  However, neither assessment tool had an MCID established in 
the literature making it more difficult to discern how meaningful the improvements were 
to actual function.  It is important to note that the MAS and BBS are scored on an 
ordinal scale that require a subjective judgment from the assessor.  The evidence would 
have been stronger if the authors included continuous data, such as gait speed, to 
eliminate subjectivity.   
 
Several minor threats to internal validity were lack of exclusion criteria, maturation, 
testing effect, selection, and lack of blinding of subjects and therapists.  It is possible 
that subjects were included with cognitive deficits because they were not explicitly 
excluded.  Thus, the ability to follow commands may have differed between subjects 
and decreased the efficacy of treatments. Maturation was a minor threat. Subjects post 
stroke may experience spontaneous recovery, but it was likely equitable between 
groups since they were similar in number of days post stroke.  Testing effect was a 
minor threat since subjects likely performed better each time they received a particular 
assessment.  Selection was a minor threat since subjects were a sample of 
convenience.  Lack of blinding of subjects and therapists introduced the Hawthorne and 
Rosenthal effects.  A moderate threat to internal validity was that although subjects 
were similar in demographics, they appeared different at baseline on the BBS. 
 
Evidence:  The MAS and BBS scores were rated prior to treatment and after 4 weeks 
for all subjects. Within group comparisons were assessed with a paired t-test and 
between group comparisons were assessed with an independent t-test.  Subjects 
appeared similar at baseline in terms of the MAS.  It is unclear if subjects were similar 
or different at baseline on the BBS. 
 
Table 7 : MAS scores (out of 30) at baseline and at 4 weeks for subjects with 
spasticity and between group effect size. 
Group Mean MAS Score at 
Baseline 
Mean MAS Change  
Score 
Between Groups 
Effect Size 
(95% CI) 
Bobath  
(n=10) 
11.18 (± 4.02) 7.64 (± 4.03)  
1.17 (0.24 to 2.10) 
Orthopedic 
(n=11) 
11.33 (± 4.62) 4.00 (± 1.95)  
Participants in both groups improved significantly on the MAS (p<0.001).  Subjects in 
the Bobath group showed significantly greater improvements in terms of change scores 
(p=0.011).  The effect size of 1.17 was large favoring the Bobath group, but was 
associated with a wide confidence interval of 0.24 to 2.10 suggesting that future 
treatment effects may vary from small to large. 
 
 
Table 8: BBS scores (out of 56) at baseline and at 4 weeks for subjects with 
spasticity and effect sizes of within group changes. 
Group Mean BBS Score 
at Baseline 
Mean BBS 
Change  Score 
Met MDC Within Group Effect 
Size (95% CI) 
Bobath  
(n=10) 
6.09 (± 4.57) 14.55 (± 10.76) yes 1.57 (.57 to 2.57) 
 
Orthopedic 
(n=11) 
10.67 (± 6.49) 9.75 (± 4.85) yes 1.65 (.68 to 2.62) 
Both groups demonstrated significant improvements on the BBS over the course of 
treatment (p ≤ 0.001) and both groups surpassed the MDC of 6.9 points.  However, 
there was no difference between groups in terms of mean changes scores. The within 
group effect sizes were large for both groups with similar confidence intervals 
demonstrating both treatments had an equitable effect. 
 
Applicability of study results: 
Benefits vs. Costs: The Bobath and orthopedic approaches to therapy both 
demonstrated significant benefits to patients with hemiparesis.  Both groups showed 
improvements on the BBS surpassing the effect size.  Additionally, subjects in the 
Bobath group demonstrated even greater change on the MAS with a large effect size.  
The Bobath approach does not require any additional cost or time than an orthopedic 
approach and both groups participated in the same amount of therapy.   
 
Feasibility of treatment: Treatment was provided 5 times a week for 4 weeks for forty 
minutes which is feasible in acute care and inpatient rehabilitation centers.  The Bobath 
approach involves different manual and sensory facilitation approaches which do not 
require any additional equipment.  Therapists need to receive additional training in order 
to be proficient in these techniques, but there are numerous continuing education 
opportunities making this a feasible option. 
 
Summary of external validity: The patient population in this study was similar to the 
population of interest in acuity of stroke, age, and resulting motor impairments. 
Additionally, the Bobath approach was feasible to perform and demonstrated benefit to 
the subjects.  However, the authors did not include long term follow up data on the 
group with spasticity so it is unclear how effective the Bobath approach is in aiding 
subjects to maintain or further improve function.  The internal validity of this study was 
fair and subjects were a convenience sample from a single clinic.  This slightly 
compromises the ability to generalize these results to other subjects with hemiparesis 
post stroke. 
 
 
Article 3: Van Vliet PM, Lincoln NB, and Foxall A. Comparison of Bobath based and 
movement science based treatment for stroke: a randomised controlled trial. Journal of 
Neurology, Neurosurgery, & Psychiatry 2005; 76: 503–508. 
 
 
Clinical Bottom Line: Based on the results of this study, there is moderate evidence to 
suggest that for subjects post acute stroke resulting in hemiparesis an intervention of  
Bobath Based (BB) treatment results in similar outcomes when compared to a 
Movement Science Based (MSB) treatment.  There were no statistically significant 
differences between groups on the Rivermead Motor Scale (RMS), Motor Assessment 
Scale (MAS), or gait speed with measurements utilizing area under the curve (AUC).  
Mann-Whitney U tests did reveal a statistically significant difference between supine to 
sitting scores on the MAS which favored the BB group.  Results were reported in terms 
of median scores and inter-quartile ranges (IQR) so it was not possible to calculate 
numbers needed to treat or effect sizes.   
 
Minor threats to validity were maturation, testing effect, convenience sampling, and lack 
of blinding of subjects and therapists.  However, this study included blinding of 
assessors, adequate power, and an adequate control group.  The population also 
matched the patient of interest to this clinical question in terms of age and onset of 
stroke. Therefore, it is reasonable to expect similar results across the population of 
stroke survivors.   
 
It would be beneficial to see further research reporting on mean change scores and 
standard deviations in order to explore the efficacy of each treatment approach.  Neither 
treatment approach demonstrated statistically significant within group change in terms 
of gait speed and the MSB within group change was significant on the RMS. 
 
  
Article PICO: 
• Population:120 stroke survivors less than 2 weeks post stroke 
• Intervention: Bobath based treatment 
• Comparison: Movement Science based treatment 
• Outcome measures: Rivermead Motor Scale, Motor Assessment Scale, Gait 
speed  
 
Blinding: Subjects and therapists were not blinded.  Therapist blinding would have 
been difficult since they were provided with detailed written instruction on the objectives 
for each treatment approach and those providing the MSB treatment received additional 
training.  The assessor was blinded to group allocation.   
 
 
Controls: Controls included randomized group allocation and blinding of assessors. 
The MSB treatment served as an adequate comparison group because the authors 
demonstrated in another article that the two approaches are significantly different in 
terms of content.9  Frequency and duration of therapy was not standardized, but 
treatment time was not significantly different between groups.   
 
 
Randomization: Subjects were screened for inclusion as they were admitted and then 
assessed.  After assessment, the subjects were randomly allocated to a treatment 
group by a computer generated random sequence.  Groups were similar at baseline in 
terms of age, gender, hemisphere of stroke, size and location of infarct, and cognition.  
Additionally, there was no statistical difference between groups at baseline in terms of 
the MAS, RMS, or gait speed. 
 
 
Study: This study included 120 subjects from  a single rehabilitation center.  Inclusion 
criteria required subjects be post stroke with a physical therapy referral.  Subjects were 
excluded if they were more than 2 weeks post stroke, unconscious when admitted to the 
hospital, not independent with activities of daily living prior to the stroke, lived more than 
25 km from the hospital, were unable to tolerate more than half an hour of physical 
activity at evaluation, or did not provide informed consent. 
 
Subjects received initial BB treatment before randomization into groups and were then 
randomly allocated to a BB or MSB treatment group within two weeks of onset of stroke.  
Subjects in the BB group had a mean age of 73.3 years and a mean of 75 years in the 
MSB group.  The BB approach focused on normalization of tone and manual facilitation 
techniques.  The MSB approach focused on task specific practice, prevention of soft 
tissue contracture, and cognitive strategies for movement planning.  Subjects continued 
their allocated treatment approach throughout the duration of outpatient therapy 
services and when they worked with occupational therapists.  There was no 
standardized duration or frequency of treatments and subjects received therapy based 
on individualized need.  Subjects received a median of 23 minutes of treatment a day 
(IQR 13-32) and total therapy time was a median of 365 minutes (IQR 140-1160).   
 
Outcome measures: Subjects were assessed at 1 month, 3 months, and 6 months post 
random allocation to a treatment group by a blinded assessor in a room separate from 
the ward.  Assessments made at 1 month and 6 months were sufficient to analyze this 
clinical question. 
 
RMA is an assessment tool of motor performance with 3 domains including gross 
function, leg and trunk movement, and arm movement.  It has been established in the 
literature as a valid and reliable assessment tool of function in the stroke population.10  
Subjects are rated a 1 if they can perform a certain activity and 0 if they cannot for a 
total of 38 available points.  Tasks include transfers, sitting balance, ambulation, stairs, 
running, hopping, and upper and lower extremity strength and range of motion. 
 
As mentioned previously, the gait speed and the MAS are reliable and valid assessment 
tools in the stroke population.3,4,7  The MAS assesses 8 areas of motor function and 
each item is scaled from 0 to 6 for a total of 48 available points.   There is no MDC or 
MCID established in the literature.  The MCID for gait speed is 0.16 m/s.3,4 
 
Study losses:  
Table 9: Group losses at 1 month, 3 months, and 6 months 
Group Initial Group 
Size 
Losses at 1 
month 
Losses at 3 
months 
Losses at 6 
months 
BB 60 8 
(52 assessed) 
17 
(43 assessed) 
15 
(45 assessed) 
MSB 60 13 
(47 assessed) 
18 
(42 assessed) 
18  
(42 assessed) 
60 subjects were included in each group.  Subjects were lost for varying reasons at 
each time point including refusal to participate, administrative errors, illness, and death. 
 
 
Summary of internal validity: Overall this study demonstrated good internal validity. 
Strengths of the study were adequate definitions of inclusion criteria, random allocation 
to treatment groups, blinding of assessors, adherence to a strict protocol, and inclusion 
of a long term follow-up.  The authors performed a power calculation indicating 78 
subjects were necessary to see a difference between groups on the RMS with 80% 
power.  Group size varied from 45-52 subjects depending on study losses, but always 
surpassed the requirement of 78 total subjects to prevent a type 2 error.  Additionally, 
although the study had several subject losses, an intention to treat analysis was 
included in the statistics.  Reason for study losses were defined for each group and 
none of them appeared secondary to poor tolerance of treatment sessions.  Although 
there was no frequency and duration were not standardized, the authors reported no 
statistically significant difference between groups in terms of treatment time.  
 
 Assessment tools were reliable and valid for the stroke population.  However, the MAS 
and RMS do not have MCID values established in the literature making it more difficult 
to discern how meaningful the improvements were to actual function.  Additionally, the 
authors reported on differences between groups, but did not comment as to the 
significance of within group change.  Therefore, it is unclear how effective the 
treatments were on function.   It would have been valuable to include mean scores and 
standard deviations so that an effect size could be calculated to determine the effect 
treatment had on function. 
 
Several minor threats to internal validity were maturation, testing effect, selection, and 
lack of blinding of subjects and therapists.  Maturation was a minor threat because 
although subjects post stroke may experience spontaneous recovery, subjects were 
similar at baseline in demographics and function.  Testing effect was a minor threat 
since subjects likely performed better each time they received a particular assessment.  
Selection was a minor threat since subjects were a sample of convenience.  Lack of 
blinding of subjects and therapists introduced the Hawthorne and Rosenthal effects. 
 
Evidence: The authors compared outcomes between groups with analysis of serial 
measurements utilizing area under the curve where outcome scores were plotted 
against time.  The AUC values were then compared with Mann-Whitney U tests to get 
an appreciation of response of time. All statistical analyses were by intention to treat to 
account for study losses. 
 
Table 10: Median gait speeds and IQR at 1 month and 6 months post treatment. 
Group Median Gait Speed at 1 
month (m/s) 
Median Gait Speed at 6 
months (m/s) 
BB  (n=52)  0.69  
IQR (0.41 - 0.86) 
(n=45)  0.76 
IQR (0.5 – 0.9) 
MSB (n=47)  0.64 
IQR (0.47 – 1.02) 
(n=42)  0.64 
IQR (0.37 – 0.91) 
Table 10 demonstrates the reported median values for gait speed at 1 month and 6 
months post treatment.  The authors reported that there was no significant difference 
between groups at either time interval.  The within group change was not significant for 
either group. 
 
 
 
 
  
Table 11:  RMS median scores (out of 38) and IQR at baseline, 1 month, and  6 
months 
Group Median Score at 
Baseline 
Median Score at 1 
month 
Median Score at 6 
months 
BB  (n=60)  2  
IQR (1-6) 
(n=52)  7 
IQR (3-9) 
(n=45)  8 
IQR (6-10) 
MSB (n=60)  1 
IQR (1-4) 
(n=47)  6 
IQR (2-9) 
(n=42)  8 
IQR (6-10) 
Table 11 demonstrates the median scores on the RMS at baseline, 1 month, and 6 
months post treatment.  The authors reported there was no statistical difference 
between groups at any time interval.  MSB within group change was statistically 
significant. 
 
 
Table 12: MAS supine to sitting scores (out of 6) and IQR at baseline, 1 month, 
and 6 months 
Group Median Score at 
Baseline 
Median Score at 1 
month 
Median Score at 6 
months 
BB  (n=60)  4  
IQR (2-6) 
(n=52)  6 
IQR (5-6) 
(n=45)  6 
IQR (6-6) 
MSB (n=60)  2 
IQR (2-6) 
(n=47)  6 
IQR (2-6) 
(n=42)  6 
IQR (4-6) 
A Mann-Whitney U test showed that at 6 months there was a statistically significant 
difference on the supine to sitting scores on the MAS in favor of the BB group.  No other 
difference were found on other items on the MAS.  Additionally, the  AUC found no 
difference between groups overall. 
 
 
Applicability of study results: 
Benefits vs. Costs: Treatment time was equitable between groups and there was no 
significant difference between number of days in the hospital or place of discharge.  
Therefore, there does not seem to be a clear benefit in terms of one treatment over the 
other.  In terms of therapist training, either treatment approach may be emphasized over 
the other in a particular academic setting.  Therefore, it is dependent on a particular 
therapist’s background whether additional training would be necessary. 
 
Feasibility of treatment:  The BB approach is a feasible in an inpatient or outpatient 
rehabilitation setting.  A study of the differences of the two treatment approaches 
revealed that the BB group contained the use of more physiotherapy equipment 
whereas everyday objects were used in the MSB group.8  However, the equipment used 
were items regularly available in treatment settings including wheelchairs, cones, floor 
mats, and parallel bars. 
 
Summary of external validity: The patient population in this study matched the 
population of interest in acuity of stroke, age, and resulting motor impairments.  The 
interventions were feasible to perform in a rehabilitation setting, but were not detailed so 
it would be difficult to recreate the exact interventions.  The overall internal validity of 
this study was good which allows the generalization of these results to the larger 
population of patients post stroke resulting in hemiparesis. 
 
Article 4: Langhammer B and Stanghelle JK. Bobath or Motor Relearning Program? A 
comparison of two different approaches of physiotherapy in stroke rehabilitation: a 
randomized controlled study. Clinical Rehabilitation 2000; 14:361–369. 
 
Clinical Bottom Line: Based on the results of this study, there is moderate evidence to 
suggest that for patients post CVA resulting in hemiparesis an intervention based on a 
Bobath approach results in slightly less favorable outcomes when compared to a Motor 
Relearning Program (MRP).  Assessments pertinent to this clinical question were the 
Motor Assessment Scale (MAS) and Sodring Motor Evaluation Scale (SMES).  Both 
scales are reliable and valid for the stroke population to assess function and are rated 
on an ordinal scale.  Groups were assessed at baseline and three months post stroke.  
The authors reported the MRP group demonstrated statistically significant greater 
improvements on the MAS (p=0.016) than the Bobath group.  However, the effect size 
was small (0.30) and the confidence crossed zero indicating future trials could have 
resulted in more favorable outcomes for the Bobath group.  This was a similar finding on 
the SMES part 1 regarding leg function and SMES part 3 regarding trunk and gait.  
Between group analyses for both subscales demonstrated small effect sizes (0.18 and 
0.10 respectively) with the lower range of the confidence intervals crossing zero. 
Therefore, both treatments were equitable.  The MRP group did have a statistically 
significant shorter length of stay of 21 days compared to 34 days for the Bobath group 
(p= 0.008).  This suggested that MRP approach was slightly more favorable than the 
Bobath approach in terms of conservation of resources.  
 
This study had good internal validity and included subject and assessor blinding, 
random allocation to treatment groups, adequate power, and adherence to a strict 
protocol.  However, an intention to treat analysis was not performed in regards to study 
losses and there was no inclusion of a long term follow-up.  However, these threats do 
not limit the ability to generalize these results to a greater population of stroke survivors.  
Subjects had a mean age greater than the patient of interest, but included subjects in 
his age range.  Additionally, subjects were evaluated soon after stroke and treatment 
was initiated in an acute care setting.  It would be beneficial to see future research 
including continuous data such as gait speed and use of outcome tools with established 
MDCs to ascertain how relevant increases in function were.   
 
 
Article PICO: 
• Population: 61 stroke survivors with hemiparesis and first stroke 
• Intervention: Bobath    
• Comparison: Motor Relearning Program 
• Outcome measures: Sodring Motor Evaluation Scale, Motor Assessment Scale 
 
 
Blinding:  Subjects and assessors were blinded to group allocation.  Therapists were 
not blinded. 
 
 
Controls: Controls included blinding of subjects and assessors, adherence to a strict 
protocol, inclusion of a comparison group, use of valid and reliable assessment tools, 
and standardized frequency and duration of treatment. This is a list, not a complete 
sentence 
 
 
Randomization: Subjects were randomly allocated to two treatments groups and 
stratified according to gender and hemisphere affected.  Subjects were similar at 
baseline in terms of age and baseline scores on the MAS and SMES suggesting 
randomization was successful.   
 
 
Study:  This double-blind study included 61 subjects  recruited from a single hospital. 
Inclusion criteria consisted of first time stroke resulting in hemiparesis that was verified 
by computerized tomography.  Subjects were excluded if they had a previous stroke, 
subarachnoid hemorrhaging, tumors of the brain, severe comorbidities, or scored five or 
greater on each of the MAS items.  Mean age of the subjects was 78 years. 
 
Subjects were randomized to a Bobath group or MRP group and then stratified 
according to gender and hemisphere affected.  Each subject received physical therapy 
5 days a week for a minimum of 40 minutes for as long as they were hospitalized.  The 
plan of care varied for subjects post discharge from the hospital.  Most subjects 
continued their allocated treatment approach after discharge via home health therapy, 
rehabilitation centers, or outpatient physical therapy services.  Inpatient physical 
therapists sent specific instructions to the therapists continuing treatment and also 
engaged in meetings to coordinate continuity of care.  Subjects who were independent 
in activities of daily living at discharge or subjects who were deemed dependent in 
personal care did not receive follow-up physical therapy.   
 
Outcome measures: Patients were assessed three days after hospital admission, two 
weeks after baseline assessment, and three months post stroke.  Assessments 
pertinent to this clinical question were the MAS and SMES.  All tests were tested by the 
authors for reliability and validity. 
 
As mentioned previously, the MAS is a reliable and valid assessment tool in the stroke 
population.2,3,6  It assesses 8 areas of motor function and each item is scaled from 0 to 
6 for a total of 48 available points.   Examples of items include turning, sitting, standing, 
and walking.  There is no MDC or MCID established in the literature.   
 
The SMES is a motor function scale which only assess unassisted performance of the 
subject and includes an assessment of quality of movement.  It is a reliable and valid 
assessment tool for the stroke population.10  It has 32 items with three subscales 
including leg function. arm function, and trunk/balance/gait function.  There is limited 
information about administering this assessment in the literature and no information on 
scoring, MDC, or MCID. 
 
Study Losses:  A total of 4 subjects were lost from each of the treatments groups.  
Subjects were lost due to death or because subjects moved out of the area.  Specifics 
were not given for each group’s losses.  There was not an intention to treat analysis. 
 
 
Summary of internal validity: 
Overall this study demonstrated good internal validity. Strengths of the study were 
adequate definitions of inclusion and exclusion criteria, random allocation to treatment 
groups, stratification of groups into age and hemisphere affected, blinding of subjects 
and assessors, and similarity of subjects at baseline.  Additionally, subjects received the 
same frequency and duration of treatment while at the hospital and therapists adhered 
to a strict protocol. 
 
Minor threats to internal validity were maturation, testing effect.  Maturation was a minor 
threat because subjects were similar at baseline and the same level of spontaneous 
recovery would be expected. Testing effect was also a minor threat since subjects likely 
performed better each time they received a particular assessment.  Selection was a 
minor threat to the study since subjects were a convenience sample chosen from a 
single hospital.  
 
This study had good to fair statistical validity.  The authors used valid and reliable 
assessment tools and appropriate statistical measures.  However, both assessments 
are rated on an ordinal scale, requiring a subjective component to scoring.  It would 
have been beneficial to include continuous data such as gait speed to eliminate any 
rater bias.  A power calculation performed by the authors required 51 subjects be 
included in the study and 61 were recruited to prevent a type 2 error.  However, both 
groups had a total of 4 subjects losses and authors did not perform an intention to treat 
analysis.  Therefore, follow- up assessments do not reflect how the scores would have 
changed if the subjects had an unfavorable response to the treatment.  Additionally, 
authors included a 3 month follow up, but no long term follow-up to decipher if the 
treatments had different lasting effects.   
 
 
Evidence:   Group results were assessed with Student’s t-tests and ANOVAs where 
used for differences between repeated measurements.  The authors did not provide 
mean change scores so mean scores at 3 months were compared to ascertain between 
groups differences.  Subjects were not statistically different at baseline on the MAS or 
SMES subscales. 
 
Table 13 : MAS mean scores (out of 48) at 3 months post stroke and between 
group effect size. 
 
Group Mean MAS Score at 
3 months 
Between Group 
Effect Size (95% CI) 
Bobath  
(n=24 at 3 months) 
 
33 (± 15) 
 
0.30 (-0.25 to 0.84) 
MRP 
(n=29 at 3 months) 
 
37(± 12) 
 
Table 13 shows the mean MAS scores at 3 months for both the Bobath and MRP 
groups.  The between group effect size was small (0.30) and favored the MRP group.  
However, the lower end of the 95% confidence interval crossed zero indicating that if 
this study were repeated the results could have favored the Bobath group.  Therefore, 
there is less confidence the MRP approach is a superior treatment. 
 
 
Table 14 : SMES part 1 sumscores at 3 months post stroke and between group 
effect size.  
Group Mean SMES 
Sumscore at 3 
months 
Between Group 
Effect Size (95% CI) 
Bobath  
(n=24 at 3 months) 
 
16 (± 6) 
 
0.18 (-0.36 to 0.72) 
MRP 
(n=29 at 3 months) 
 
17(± 5) 
 
Table 14 shows the mean SMES part 1 sumscores regarding  leg function at 3 months 
for the Bobath and MRP groups.  The between group effect size was small (0.18) and 
favored the MRP group.  However, the lower end of the 95% confidence interval 
crossed zero indicating that future trials could have resulted in more favorable outcomes 
for the Bobath group..  Therefore, there is less confidence the MRP approach is a 
superior treatment. 
 
 
Table 15 : SMES part 3 sumscores at 3 months post stroke and between group 
effect size. 
Group Mean SMES 
Sumscore at 3 
months 
Between Group 
Effect Size (95% CI) 
Bobath  
(n=24 at 3 months) 
 
39 (± 21) 
 
0.10 (-0.44 to 0.64) 
MRP 
(n=29 at 3 months) 
 
41(± 18) 
 
Table 15 shows the mean SMES part 3 sumscores regarding  trunk function, balance 
and gait at 3 months for the Bobath and MRP groups.  Similar to the previous two 
comparisons, the effects was small (0.10) and favored the MRP group.  However, the 
lower end of the 95% confidence interval crossed zero indicating that future trials could 
have resulted in more favorable outcomes for the Bobath group.  Therefore, there is 
less confidence the MRP approach is a superior treatment. 
 
 
Applicability of study results: 
Benefits vs. Costs:  Between group differences demonstrated small effect sizes favoring 
the  MRP group.  However, since the lower range of the confidence interval crossed 
zero on all outcome measures, it is not clear which treatment provides more benefit to 
the patient.  The authors did report the  MRP group had a statistically significantly 
shorter length of  stay with a mean of 21 days while the Bobath group had a mean stay 
of 34 days (p=0.008).  Therefore, the MRP demonstrated a slight benefit in terms of 
patient function and conservation of resources. 
 
Feasibility of treatment:  Neither treatment approach was explicitly described by the 
authors.  However, both approaches are consistently used in inpatient and outpatient 
rehabilitation settings.  Both approaches are available via continuing education courses 
and neither require special equipment.  Additionally, the frequency and duration of 
therapy was not excessive and similar to what is administered at current rehabilitation 
settings. 
 
Summary of external validity: The patient population in this study matched the 
population of interest in acuity of stroke, age, and resulting motor impairments.  The 
interventions were feasible to perform and had reasonable frequencies and durations.  
A minor threat to the external validity was that subjects were a sample of convenience 
from a single hospital.  However, the internal validity of this study was good which 
supports the ability to generalize these results to the larger population of patients post 
stroke resulting in hemiparesis.   
 
 
 
Synthesis/Discussion  
Authors of all four studies examined the inclusion of a Bobath rehabilitative approach to 
determine its effectiveness on increasing function in patients post stroke resulting in 
hemiparesis as compared to other programs that did not include a Bobath approach. All 
four studies had similar populations which were adults encountered in an acute care 
setting with hemiparesis secondary to a stroke.  Two studies excluded subjects with 
histories of previous strokes and three excluded subjects with some baseline functional 
deficits. 
 
 
The four studies varied slightly in their methodological quality, but together provided 
moderate evidence to support the overall clinical bottom line.  In all of the studies, 
subjects were randomly allocated subjects to groups.  All groups were similar at 
baseline on functional outcome measures with the exception of the groups in Wang et 
al. where it was not explicitly stated.  Assessors were blinded in the all of the studies 
except for Gebler et al., which decreased the risk of rater bias.  Three of the studies had 
subject losses which surpassed 15% of the total number of subjects per group.  Only 
Van Vliet et al. included an intention-to-treat analysis to identify what the change in 
scores on the functional outcome measures would have been had the subjects lost had 
unfavorable responses to the interventions.   Van Vliet et al. and Langhammer et al. 
demonstrated adequate power, including subject losses, to avoid a type II statistical 
error.  Gebler et al.and Wang et al. did not meet adequate power, which introduced this 
error.  Overall, Gebler et al. demonstrated poor  internal validity, Wang et al. 
demonstrated fair internal validity, and Van Vliet et al. and Langhammer et al. 
demonstrated good internal validity,  Therefore, the results of the latter three studies 
were more closely examined. 
 
The Bobath intervention group was consistent across the four studies and all 
comparison groups excluded its principles.  Therefore, it was possible to determine if 
the inclusion of a treatment based on the Bobath approach increased function as 
compared to other programs.  In all four articles, patients who received Bobath physical 
therapy in an acute care setting demonstrated statistically significant increases in 
function.  However, the increases in function were either not statistically different than 
the improvements noted in comparison groups or Bobath group effect sizes were 
slightly lower.  Gelber et al., found no difference between the Bobath group and the 
Traditional Functional Retraining group in gait speed or scores on the FIM.  This was 
similar to the outcomes in Wang et al.  where improvement found in the Bobath group 
on the BBS was no different than subjects in the orthopedic group.  Van Vliet et al. and 
Langhammer et al. both had good internal validity,  Van Vliet et al. demonstrated the 
Bobath approach was no different than a Movement Science Based in terms of 
outcomes on the Rivermead Motor Scale, Motor Assessment Scale, or gait speed.  
Lastly, Langhammer et al provided moderate evidence that the Bobath approach was 
slightly less favorable when compared to a Motor Relearning Program (MRP).  Although 
groups were similar on the SMES and MAS, the MRP group had a statistically 
significant shorter length of hospital stay.  Therefore,  the overall conclusion is that the 
addition of a Bobath approach did not further increase patient function or provide 
additional benefits to patients. 
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